Expert Ratings for OncoCyte Within the last quarter, OncoCyte (NASDAQ:OCX) has observed the following analyst ratings: Benzinga · May 12, 2022
OncoCyte: Q1 Earnings Insights OncoCyte (NASDAQ:OCX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings OncoCyte reported in-line EPS of $-0.12 versus an estimate of $-0.12. Benzinga · May 11, 2022
2 Stocks Under $2 Insiders Are Aggressively Buying Gold futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading… Benzinga · Apr 19, 2022
4 Stocks Under $5 Insiders Are Aggressively Buying US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading… Benzinga · Apr 18, 2022
What 4 Analyst Ratings Have To Say About OncoCyte OncoCyte (NASDAQ:OCX) has observed the following analyst ratings within the last quarter: Benzinga · Mar 18, 2022